ProQR Therapeutics N.V. (PRQR) Stock Forecast
Data as of May 10, 2026Healthcare · Current price $1.59 (+0.95%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
PRQR vs Sector & Market
| Metric | PRQR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +127.6% | +1710.8% | +16.4% |
| P/E Ratio | -3.09 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $4M | $4M | $4M | 3 |
| 2026-09-30 | $4M | $4M | $5M | 1 |
| 2026-12-31 | $4M | $4M | $4M | 2 |
| 2027-12-31 | $12M | $18M | $24M | 3 |
| 2028-12-31 | $67M | $70M | $73M | 3 |
| 2029-12-31 | $93M | $120M | $145M | 2 |
| 2030-12-31 | $350M | $451M | $543M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.14 | $-0.13 | $-0.12 | 5 |
| 2026-09-30 | $-0.15 | $-0.13 | $-0.11 | 1 |
| 2026-12-31 | $-0.16 | $-0.14 | $-0.12 | 1 |
| 2027-12-31 | $-0.86 | $-0.61 | $-0.40 | 5 |
| 2028-12-31 | $-0.68 | $-0.32 | $0.08 | 4 |
| 2029-12-31 | $0.06 | $0.08 | $0.11 | 2 |
| 2030-12-31 | $1.71 | $2.42 | $3.06 | 2 |
Frequently Asked Questions
What is the analyst consensus for PRQR?
The consensus among 1 analysts covering ProQR Therapeutics N.V. (PRQR) is Buy with an average price target of $3.63.
What is the highest price target for PRQR?
The highest analyst price target for PRQR is $5.00.
What is the lowest price target for PRQR?
The lowest analyst price target for PRQR is $2.00.
How many analysts cover PRQR?
1 analysts have issued ratings for ProQR Therapeutics N.V. in the past 12 months.
Is PRQR a buy or sell right now?
Based on 1 analyst ratings, PRQR has a consensus rating of Buy (2.00/5) with a +127.6% upside to the consensus target of $3.63.
What are the earnings estimates for PRQR?
Analysts estimate PRQR will report EPS of $-0.13 for the period ending 2026-06-30, with revenue estimated at $4M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.